Speaking of SurgOnc-logo

Speaking of SurgOnc

Podcasts

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.

Location:

United States

Genres:

Podcasts

Description:

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.

Language:

English

Contact:

8474271400

Episodes

Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies

8/11/2020
Rick Greene, MD and Giorgos Karakousis, MD discuss the impact of immune checkpoint and BRAF/MEK pathway inhibitors on outcomes and melanoma care at a national population level in patients diagnosed with clinical stage III melanoma. Dr. Karakousis is author of, “Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies.” Dr. Karakousis is Associate Professor of Surgery at the Hospital of the University of Pennsylvania, Philadelphia, PA.

Duration:00:07:51

Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases

7/14/2020
Rick Greene, MD, and Michael D’Angelica, MD discuss the relationship between hepatic parenchymal disease and recurrence after colorectal liver metastases resection, which has not been well defined. Dr. D’Angelica is author of, “Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.” Dr. D’Angelica holds the Enid A. Haupt Chair in Surgery at Memorial Sloan Kettering Cancer Center and is Professor of Surgery at Weill Medical College...

Duration:00:06:58

Cancer Network Affiliations: Implications and Opportunities for Cancer Care Quality

7/1/2020
Lesly Dossett, MD interviews SSO member Dan Boffa, MD about his work that explores the rationale and potential advantages of cancer networks, while also reviewing the data on patient perceptions and surgical quality within cancer networks.

Duration:00:36:30

Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility

6/9/2020
Rick Greene, MD and Elizabeth Grubbs, MD, MS discuss an analysis of the applicant pool of complex general surgical oncology (CGSO) fellowships and how it has changed over the last decade. Dr. Grubbs is author of, “Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility.” Dr. Grubbs is Associate Professor, Program Director of Complex General Surgical Oncology Fellowship, Vice Chair of Education, Department of Surgical...

Duration:00:07:55

Symptom burden at the end-of-life for neuroendocrine tumors: an analysis of 2,579 prospectively collected patient-reported outcomes

5/12/2020
Rick Greene, MD and Julie Hallet, MD discuss the moderate-to-severe symptoms observed to steeply increase as death nears for patients with neuroendocrine tumors (NETs), which highlight an opportunity for improved management. Dr. Hallet is author of, “Symptom Burden at the End of Life for Neuroendocrine Tumors: An Analysis of 2579 Prospectively Collected Patient-Reported Outcomes.” Dr. Hallet is Assistant Professor, Surgical Oncology, University of Toronto and Sunnybrook Health Sciences...

Duration:00:07:27

Germline Genetic Testing: What the Breast Surgeon Needs to Know

4/7/2020
Dr. Greene and Dr. Plichta discuss the potential benefit for women from genetic testing for BRCA1, BRCA2, and other breast cancer genes and the knowledge needed by breast surgeons to facilitate testing and counseling. Dr. Plichta is author of, “Germline Genetic Testing: What the Breast Surgeon Needs to Know.” Dr. Plichta is an Assistant Professor of Surgery, Division of Surgical Oncology, Duke Surgery, Duke University School of Medicine, Durham, NC.

Duration:00:07:46

Maintenance of Certification and Continuing Medical Education: Are They Still Required?

3/10/2020
Rick Greene, MD and Marissa M. Howard-McNatt, MD discuss how the requirements for maintenance of certification (MOC) and CME changed in 2018, and review the options for completing these requisites. Mariss M. Howard-McNatt, MD is author of, “Maintenance of Certification and Continuing Medical Education: Are They Still Required?” Marissa M. Howard-McNatt, MD is an Associate Professor of Surgery Sciences – Oncology, Wake Forest School of Medicine, Winston-Salem, NC. She is the Director of the...

Duration:00:12:40

Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer

2/11/2020
Dr. Greene and Dr. Jeruss discuss the potential impact of treatment on the future fertility of young breast cancer patients and review guidelines provided to address reproductive health in conjunction with a breast cancer diagnosis. Dr. Jeruss is author of, “Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.” Dr. Jeruss is an Associate Professor of Surgery at Departments of Surgery, Pathology, and Biomedical Engineering,...

Duration:00:10:03

Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy

1/21/2020
Dr. Rick Greene and Dr. Andrew J. Rosko discuss how intraoperative usage of indocyanine green imaging can predict the formation of post-operative fistulas, allowing for more tailored reconstructive options depending on risk of fistula. Dr. Rosko is author of, “Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy.” Dr. Rosko is a Clinical Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, at the University of Michigan...

Duration:00:07:21

Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group

12/10/2019
Dr. Rick Greene and Dr. Paxton Dickson discuss adrenocortical carcinoma and related issues regarding adjuvant and neoadjuvant therapy, treatment of advanced disease, and genetic considerations for patients who have this disease. Dr. Dickson is author of, “Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group.” Dr. Dickson currently serves as an...

Duration:00:09:23

Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy

11/12/2019
Dr. Rick Greene and Dr. Clancy Clark discuss the use of a modified frailty index as a predictor in pancreaticoduodenectomy, its association with postoperative morbidity and mortality, and how it can aid in preoperative risk stratification. Dr. Clark is author of, “Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy.” Dr. Clark is an Assistant Professor, Department of Surgery, at Wake Forest Baptist Health in Winston-Salem, NC. He is a hepatobiliary and...

Duration:00:10:12

Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients

10/8/2019
Dr. Rick Greene and Dr. Basem Azab discuss the relationship of the interval between neoadjuvant chemoradiation-to-surgery in the treatment of esophageal cancer, and associated pathological complete response rate and overall survival rate. Dr. Azab is author of the Annals of Surgical Oncology article “Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients.” Dr. Azab is a surgical oncology...

Duration:00:09:00

8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers

9/10/2019
Dr. Greene and Dr. Pawlik will discuss the 8th edition of the TNM staging system for pancreas and hepatobiliary cancers, which affirms that the anatomic extent of disease remains the strongest predictor of outcome in hepatobiliary cancers. Dr. Pawlik is ASO Deputy Editor and Editorial Board Section Editor, Hepatobiliary Tumors. He is co-author with Yun Shin Chun and Jean-Nicolas Vauthey of the ASO TNM staging editorial, "8th Edition of the AJCC Cancer Staging Manual: Pancreas and...

Duration:00:07:34

The 8th Edition of the AJCC Cancer Staging Manual: Breast Cancer

8/13/2019
Dr. Greene and Dr. Edge will discuss the TNM staging system and its relevance to breast cancer management. Dr. Edge was Editor-in-Chief of the 7th Edition of the AJCC Cancer Staging Manual published in 2009 and co-author with Armando E. Giuliano and Gabriel N. Hortobagyi of the ASO editorial, “Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer” Dr. Edge is the Vice President for Healthcare Outcomes Policy and Professor of Oncology at the Roswell Park Cancer Institute. Dr....

Duration:00:10:06

Melanoma Staging: American Joint Committee on Cancer 8th Edition and Beyond

7/9/2019
Dr. Greene and Dr. Gershenwald discuss the 8th edition of the TNM staging system for melanoma, and its use for communication between physicians and their patients as well as its impact on decision-making and prognostic assessment. Dr. Gershenwald is co-author with Richard A. Scolyer of the ASO TNM staging editorial, “Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.” Dr. Gershenwald is a surgical oncologist-investigator in melanoma, with a research focus...

Duration:00:09:43

The 8th Edition of TNM: Implications for the Surgical Oncologist

6/11/2019
Dr. Greene and Dr. Byrd discuss the 8th edition of the TNM staging system, which through its advances supports the concept of a team approach to cancer staging by clinical oncologists including cancer registrars, pathologists, and radiologists. Dr. Byrd is co-author with Dr. Greene of the ASO TNM staging editorial, “The Eighth Edition of TNM: Implications for the Surgical Oncologist.” Dr. Byrd is the Chair of the American Joint Committee on Cancer (AJCC) and his clinical expertise includes...

Duration:00:09:30